• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

国家卫生技术评估机构中公众和患者参与活动的制度民族志分析。

An institutional ethnographic analysis of public and patient engagement activities at a national health technology assessment agency.

机构信息

Centre for Health Economics and Policy Analysis, McMaster University, Hamilton, Canada.

Health Systems Impact Fellow, McMaster University, Hamilton, Canada.

出版信息

Int J Technol Assess Health Care. 2021 Feb 9;37:e37. doi: 10.1017/S0266462321000088.

DOI:10.1017/S0266462321000088
PMID:33557969
Abstract

OBJECTIVE

The practice of public and patient engagement (PPE) in health technology assessment (HTA) has spread worldwide, yet gaps in knowledge remain. We carried out an institutional ethnography of the Canadian Agency for Drugs and Technologies in Health (CADTH) public and patient involvement in HTA.

METHODS

The research took place over 15 months and included observational work in the institutional settings, text review, and interviews with individuals working for or involved with the agency.

RESULTS

We found that despite demonstrated commitment to PPE, organizational history, governance structure, and practices were impediments to a unified approach to PPE. Unclear role descriptions for committee members and differences in philosophy and priority given to PPE across the organization presented challenges to effective participation. The high degree of value given to evidence-based principles at times conflicted with meaningful integration of patient input. A lack of clear goals and processes, roles, and differential treatment of evidence in PPE served to minimize the importance of patient experiences and to displace their validity. An acknowledgment of conflicts between multiple epistemic traditions at work within HTA activities may strengthen organizational approaches to PPE.

CONCLUSION

HTA organizations can learn from this study by reflecting on the challenges described and the recommendations offered to address them. We suggest solidifying CADTH's commitment to PPE with clear agency-wide roles and direction, values, and outcomes, a comprehensive framework, and policy and procedures. An acknowledgment of diverse epistemic traditions, as well as leadership and expertise in PPE, will strengthen CADTH's PPE activities and sustain its leadership position in the HTA field.

摘要

目的

公众和患者参与(PPE)在卫生技术评估(HTA)中的实践已在全球范围内普及,但知识差距仍然存在。我们对加拿大药品和技术评估机构(CADTH)的公众和患者参与 HTA 进行了机构民族志研究。

方法

研究历时 15 个月,包括在机构环境中的观察性工作、文本审查以及对为该机构工作或参与该机构的个人进行的访谈。

结果

我们发现,尽管对 PPE 表现出了承诺,但组织历史、治理结构和实践是实施统一 PPE 方法的障碍。委员会成员的角色描述不明确,以及组织内部对 PPE 的哲学和优先事项存在差异,这些都对有效参与提出了挑战。高度重视基于证据的原则有时与患者投入的有意义整合相冲突。缺乏明确的目标和流程、角色以及 PPE 中证据的不同处理方式,使得患者体验的重要性降低,其有效性被取代。承认 HTA 活动中存在多种认识论传统之间的冲突,可能会加强组织对 PPE 的方法。

结论

HTA 组织可以从这项研究中吸取教训,反思所描述的挑战和提出的建议,以应对这些挑战。我们建议通过明确机构范围内的角色和方向、价值观和结果、全面的框架以及政策和程序,来巩固 CADTH 对 PPE 的承诺。承认不同的认识论传统,以及在 PPE 方面的领导力和专业知识,将加强 CADTH 的 PPE 活动,并保持其在 HTA 领域的领导地位。

相似文献

1
An institutional ethnographic analysis of public and patient engagement activities at a national health technology assessment agency.国家卫生技术评估机构中公众和患者参与活动的制度民族志分析。
Int J Technol Assess Health Care. 2021 Feb 9;37:e37. doi: 10.1017/S0266462321000088.
2
PUBLIC AND PATIENT INVOLVEMENT IN HEALTH TECHNOLOGY ASSESSMENT: A FRAMEWORK FOR ACTION.公众和患者参与卫生技术评估:行动框架
Int J Technol Assess Health Care. 2016 Jan;32(4):256-264. doi: 10.1017/S0266462316000362. Epub 2016 Sep 27.
3
A HTA of what? Reframing through including patient perspectives in health technology assessment processes.一项什么样的 HTA?通过纳入患者视角重新构建卫生技术评估流程。
Int J Technol Assess Health Care. 2023 May 18;39(1):e27. doi: 10.1017/S0266462323000132.
4
Are We Making a Difference? A Qualitative Study of Patient Engagement at the pan-Canadian Oncology Drug Review: Perspectives of Patient Groups.我们是否产生了影响?一项关于泛加肿瘤药物评审中患者参与度的定性研究:患者群体的观点。
Value Health. 2020 Sep;23(9):1157-1162. doi: 10.1016/j.jval.2020.06.003. Epub 2020 Aug 7.
5
Timeliness of Health Technology Assessments and Price Negotiations for Oncology Drugs in Canada.加拿大肿瘤药物卫生技术评估与价格谈判的及时性
Clinicoecon Outcomes Res. 2024 May 25;16:437-445. doi: 10.2147/CEOR.S462872. eCollection 2024.
6
Valuing patient engagement: Reflexive learning in evidence generation practices for health technology assessment.重视患者参与:健康技术评估证据生成实践中的反思性学习。
Soc Sci Med. 2021 Jul;280:114048. doi: 10.1016/j.socscimed.2021.114048. Epub 2021 May 21.
7
Supporting quality public and patient engagement in health system organizations: development and usability testing of the Public and Patient Engagement Evaluation Tool.支持卫生系统组织中高质量的公众和患者参与:公众与患者参与评估工具的开发与可用性测试
Health Expect. 2016 Aug;19(4):817-27. doi: 10.1111/hex.12378. Epub 2015 Jun 25.
8
An international survey of the public engagement practices of health technology assessment organizations.一项针对健康技术评估组织公众参与实践的国际调查。
Value Health. 2013 Jan-Feb;16(1):155-63. doi: 10.1016/j.jval.2012.09.011.
9
Evolution of health technology assessment: best practices of the pan-Canadian Oncology Drug Review.卫生技术评估的演变:泛加拿大肿瘤药物审查的最佳实践
Clinicoecon Outcomes Res. 2015 Jun 3;7:287-98. doi: 10.2147/CEOR.S82549. eCollection 2015.
10
Patient advocate perspectives on involvement in HTA: an international snapshot.患者权益倡导者对参与卫生技术评估的看法:国际概览
Res Involv Engagem. 2017 Jan 10;3:2. doi: 10.1186/s40900-016-0052-9. eCollection 2017.

引用本文的文献

1
Global research on patient involvement in health technology assessment: a bibliometric analysis.全球关于患者参与卫生技术评估的研究:一项文献计量分析。
Glob Health Res Policy. 2025 Jul 25;10(1):30. doi: 10.1186/s41256-025-00431-z.
2
Perception of non-layperson advisory committee members on the application of a discrete choice experiment instrument to patients and advisory committee members: a qualitative study.非外行人咨询委员会成员对离散选择实验工具应用于患者和咨询委员会成员的看法:一项定性研究。
Int J Technol Assess Health Care. 2025 Feb 25;41(1):e31. doi: 10.1017/S0266462325000029.
3
A HTA of what? Reframing through including patient perspectives in health technology assessment processes.
一项什么样的 HTA?通过纳入患者视角重新构建卫生技术评估流程。
Int J Technol Assess Health Care. 2023 May 18;39(1):e27. doi: 10.1017/S0266462323000132.
4
Involving Children in Health Literacy Research.让儿童参与健康素养研究。
Children (Basel). 2022 Dec 23;10(1):23. doi: 10.3390/children10010023.
5
Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force.设计和实施卫生技术评估的审议程序:HTAi/ISPOR 联合工作组的良好实践报告。
Value Health. 2022 Jun;25(6):869-886. doi: 10.1016/j.jval.2022.03.018.
6
Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force.设计和实施卫生技术评估的审议程序:HTAi/ISPOR 联合工作组的良好实践报告。
Int J Technol Assess Health Care. 2022 Jun 3;38(1):e37. doi: 10.1017/S0266462322000198.
7
Can We Afford to Exclude Patients Throughout Health Technology Assessment?在整个卫生技术评估过程中,我们能承担得起将患者排除在外的后果吗?
Front Med Technol. 2022 Jan 25;3:796344. doi: 10.3389/fmedt.2021.796344. eCollection 2021.